- « Previous
- Clinical Pharmacology
- Next »
Lymerix
Clinical Pharmacology
Clinical Pharmacology
Lymerix
* Seropositivity defined as an IgG OspA antibody titer >/=20 EL. U./mL or a LA-2 equivalent antibody titer
³100 ng/mL.
† At month 12.
n/N = number of seropositive subjects/total subjects tested.
% = percentage of seropositive subjects.
Subjects in the placebo group did not develop detectable anti-OspA seropositivity at the sampling time points indicated in the above table.
Brand Name: Lymerix
Generic Name: Lipoprotein Outer Surface A Vaccine
Generic Name: Lipoprotein Outer Surface A Vaccine
- « Previous
- Clinical Pharmacology
- Next »
Herbal First Aid
Herbal medicine is ancient, but only in recent years have many people started to take notice of its all natural healing powers. See more WebMD Videos »
WebMD Daily
Get breaking medical news.
